Cas no 80134-83-4 (L-Leucine-1-)
L-Leucine-1- Chemical and Physical Properties
Names and Identifiers
-
- L-Leucine-1-13C-15N
- L-Leucine-1-
- CS-0376425
- (2S)-2-(15N)azanyl-4-methyl(113C)pentanoic acid
- MS-22785
- L-Leucine-1-13C,15N, 98 atom % 15N, 99 atom % 13C
- L-Leucine-1-13C,15N
- L-(1-~13~C,~15~N)Leucine
- L-Leucine-1-13C,15N, S & P tested, 99 atom % 13C, 98 atom % 15N
- HY-N0486S7
- 80134-83-4
- DTXSID20583966
- L-Leucine (1-13c, 15n)
- DA-54965
-
- Inchi: 1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m0/s1/i6+1,7+1
- InChI Key: ROHFNLRQFUQHCH-XAAHKOKXSA-N
- SMILES: O[13C]([C@H](CC(C)C)[15NH2])=O
Computed Properties
- Exact Mass: 133.095018387g/mol
- Monoisotopic Mass: 133.095018387g/mol
- Isotope Atom Count: 2
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 9
- Rotatable Bond Count: 3
- Complexity: 101
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: nothing
- XLogP3: nothing
- Topological Polar Surface Area: 63.3?2
Experimental Properties
- Color/Form: solid
- Density: 1.035
- Melting Point: >300?°C(lit.)
- PSA: 63.32000
- LogP: 1.14470
- Solubility: Not determined
L-Leucine-1- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| MedChemExpress | HY-N0486S7-5mg |
L-Leucine-1- |
80134-83-4 | ≥98.0% | 5mg |
¥500 | 2025-04-16 | |
| MedChemExpress | HY-N0486S7-10mg |
L-Leucine-1- |
80134-83-4 | ≥98.0% | 10mg |
¥800 | 2025-04-16 | |
| MedChemExpress | HY-N0486S7-25mg |
L-Leucine-1- |
80134-83-4 | ≥98.0% | 25mg |
¥1600 | 2025-04-16 | |
| MedChemExpress | HY-N0486S7-50mg |
L-Leucine-1- |
80134-83-4 | ≥98.0% | 50mg |
¥2500 | 2025-04-16 | |
| MedChemExpress | HY-N0486S7-100mg |
L-Leucine-1- |
80134-83-4 | ≥98.0% | 100mg |
¥4000 | 2025-04-16 | |
| Key Organics Ltd | MS-22785-5mg |
L-Leucine-1-13C,15N |
80134-83-4 | >97% | 5mg |
£115.79 | 2025-02-09 | |
| Key Organics Ltd | MS-22785-10mg |
L-Leucine-1-13C,15N |
80134-83-4 | >97% | 10mg |
£163.12 | 2025-02-09 | |
| Key Organics Ltd | MS-22785-100mg |
L-Leucine-1-13C,15N |
80134-83-4 | >97% | 100mg |
£661.79 | 2025-02-09 | |
| Key Organics Ltd | MS-22785-50mg |
L-Leucine-1-13C,15N |
80134-83-4 | >97% | 50mg |
£426.83 | 2025-02-09 | |
| Ambeed | A1268044-5mg |
L-Leucine-1-13C,15N |
80134-83-4 | 98% 98%atom%13C,98%atom%15N | 5mg |
$50.0 | 2025-02-27 |
L-Leucine-1- Related Literature
-
1. An integrated chip for immunofluorescence and its application to analyze lysosomal storage disordersJie Shen,Ying Zhou,Tu Lu,Junya Peng,Zhixiang Lin,Yuhong Pang,Li Yu Lab Chip, 2012,12, 317-324
-
Bidyut Kumar Kundu,Rinky Singh,Ritudhwaj Tiwari,Debasis Nayak New J. Chem., 2019,43, 4867-4877
-
Xin Li,Liangliang Zhu,Sai Duan,Yanli Zhao,Hans ?gren Phys. Chem. Chem. Phys., 2014,16, 23854-23860
-
Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
-
Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
Additional information on L-Leucine-1-
Professional Introduction to Compound with CAS No. 80134-83-4 and Product Name: L-Leucine-1
The compound with the CAS number 80134-83-4 and the product name L-Leucine-1 represents a significant advancement in the field of biochemical research and pharmaceutical development. Leucine, one of the essential amino acids, plays a crucial role in various biological processes, including protein synthesis, energy metabolism, and immune function. The specific designation L-Leucine-1 suggests a specialized form or derivative of leucine, likely optimized for particular applications in synthetic biology, drug formulation, or diagnostic assays.
In recent years, there has been a growing interest in the development of novel amino acid derivatives for therapeutic purposes. L-Leucine-1, with its precise chemical structure, may offer unique properties that make it valuable in modulating metabolic pathways or enhancing the bioavailability of other compounds. For instance, studies have shown that modified leucine derivatives can serve as precursors for peptidomimetics or as substrates for enzymatic reactions in drug synthesis. The CAS number 80134-83-4 provides a unique identifier for this compound, ensuring consistency and accuracy in scientific literature and industrial applications.
One of the most compelling aspects of L-Leucine-1 is its potential in personalized medicine. By leveraging advanced computational methods and high-throughput screening, researchers can tailor amino acid derivatives to meet specific therapeutic needs. For example, modifications to the side chain or backbone of leucine can alter its interactions with biological targets, potentially leading to more effective treatments for conditions such as metabolic disorders or cancer. The compound’s role in protein folding and stability also makes it a candidate for developing chaperone-like molecules that assist in maintaining cellular homeostasis.
Recent breakthroughs in synthetic biology have highlighted the importance of specialized amino acids in creating engineered microbes capable of producing complex biomolecules. L-Leucine-1, with its well-characterized properties, could be integrated into metabolic pathways designed to optimize the yield of pharmaceutical intermediates or biofuels. This approach not only enhances production efficiency but also reduces environmental impact by minimizing waste streams. The compound’s compatibility with existing biocatalytic systems makes it a promising candidate for industrial-scale applications.
The pharmaceutical industry has also explored L-Leucine-1 as a component in peptide-based drugs. Leucine residues are frequently found in bioactive peptides due to their hydrophobicity and stability under various conditions. By incorporating L-Leucine-1 into peptide sequences, researchers can improve drug solubility, pharmacokinetics, and target specificity. Furthermore, leucine derivatives have been investigated as carriers for nucleic acid delivery systems, where their ability to form stable complexes with DNA or RNA enhances cellular uptake and therapeutic efficacy.
Diagnostic applications of L-Leucine-1 are another area of active research. The compound’s interaction with specific enzymes or receptors can be exploited to develop highly sensitive biosensors for detecting disease biomarkers. For example, enzyme-linked immunosorbent assays (ELISAs) using L-Leucine-1 as a substrate have shown promise in early-stage diagnostics for infectious diseases and chronic conditions. Additionally, fluorescently labeled leucine derivatives serve as probes for imaging techniques, allowing researchers to visualize metabolic processes in real-time within living cells.
The synthesis of L-Leucine-1 presents unique challenges due to its structural complexity and the need for high purity levels. Advances in organic chemistry have enabled the development of efficient synthetic routes that minimize side reactions and byproduct formation. Catalytic methods, including transition metal-catalyzed cross-coupling reactions and enzymatic transformations, have been particularly successful in producing L-Leucine-1 with high enantiomeric purity. These techniques align with green chemistry principles by reducing energy consumption and hazardous waste generation.
The regulatory landscape for compounds like L-Leucine-1 is evolving to accommodate novel applications in biotechnology and medicine. Regulatory agencies now recognize the importance of specialized amino acids in drug development and provide frameworks for assessing their safety and efficacy. Manufacturers must adhere to stringent guidelines regarding quality control, contamination prevention, and batch consistency to ensure compliance with international standards such as Good Manufacturing Practices (GMP). This rigorous oversight ensures that L-Leucine-1 remains a reliable tool for scientific research and therapeutic innovation.
In conclusion,L-Leucine-1, identified by the CAS number 80134-83-4, represents a versatile compound with broad applications across multiple disciplines. Its role in protein synthesis, metabolic regulation, drug development, and diagnostics underscores its significance in modern science. As research continues to uncover new functionalities of modified amino acids like leucine derivatives,L-Leucine-1 is poised to play an increasingly important role in advancing both fundamental understanding and applied technologies within the life sciences sector.
80134-83-4 (L-Leucine-1-) Related Products
- 26011-27-8(D-Leucine-1-14C)
- 29909-01-1(DL-Leucine-d10)
- 287484-39-3(D-Leucine-15N)
- 138751-02-7((2R)-2-amino-5-methyl-hexanoic acid)
- 271247-12-2(D-Leucine-d10)
- 259225-40-6(DL-Leucine-d7 (iso-propyl-d7))
- 282726-23-2(Leucine-2-d (9CI))
- 21675-61-6(L-Leucine, labeled withtritium)
- 201612-66-0(L-Leucine-2-13C)
- 22771-58-0(L-Leucine-4,5-t2)